SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-054195
Filing Date
2017-09-27
Accepted
2017-09-27 21:39:36
Documents
1
Period of Report
2017-09-25

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5895
  Complete submission text file 0001209191-17-054195.txt   7236
Mailing Address 2225 COLORADO AVENUE SANTA MONICA CA 90404
Business Address 2225 COLORADO AVENUE SANTA MONICA CA 90404 (310) 824-9999
Kite Pharma, Inc. (Issuer) CIK: 0001510580 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

Mailing Address C/O KITE PHARMA, INC. 2225 COLORADO AVENUE SANTA MONICA CA 90404
Business Address
JENKINSON PAUL L (Reporting) CIK: 0001674528 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36508 | Film No.: 171105426